Nick Twohy Joins Imricor Executive Team

lukeNews

Imricor Medical Systems, Inc. (ASX:IMR), a leading developer of innovative MRI-compatible medical devices, announced today Nick Twohy has joined the company’s executive team as the Director of Marketing.

Amsterdam University Medical Center to be first Dutch hospital to adopt real-time MRI-guided cardiac ablations

lukeNews

Imricor announced today that it signed its first commercialization contract in the Netherlands with the Amsterdam University Medical Center, location VUmc, for the Advantage-MR™ EP Recorder/Stimulator System. With this agreement, Amsterdam UMC will become the first Dutch site to install the Advantage-MR system and perform real-time MRI-guided cardiac ablations, placing them at the forefront of clinical adoption for interventional cardiac magnetic resonance (iCMR) electrophysiology procedures.

Vision-MR Ablation Catheter Receives CE Mark

lukeNews

Imricor Medical Systems, Inc. (ASX:IMR) today announces that it has received CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. This follows earlier CE mark approval for Imricor to place its Advantage-MR EP Recorder/Stimulator System on the market in the European Union. Imricor is the first and only company to offer cardiac ablation in the MRI environment.

Heart Center Dresden to be first commercial clinical site for Imricor

lukeNews

Imricor announced today that it signed its first commercialization contract for the Advantage-MR EP Recorder/Stimulator System and supporting Vision-MR devices1 with the Heart Center Dresden in Germany. This agreement places the Heart Center Dresden at the forefront of clinical advancement for MRI-guided cardiac ablations and establishes the hospital as a world leader in the growing field of interventional cardiac magnetic resonance (iCMR).

Imricor Announces Completion of Enrollment for Clinical Study to Evaluate Vision-MR Ablation Catheter for Real-Time MR-Guided Ablations

imricordevNews

Imricor Medical Systems announced today the completion of enrollment for the clinical study to evaluate Imricor’s Vision-MR™ Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance. The single-center study enrolled 35 patients and was sponsored by the University of Leipzig Heart Center in Leipzig, Germany. Professor Gerhard Hindricks MD, Head of the Department of Electrophysiology at the Leipzig Heart Center, was the principal investigator.

Imricor Awarded NIH Contract to Develop MR Compatible Catheter for MRI-Guided Cardiac Procedures

imricordevNews

Imricor Graphic

Imricor Medical Systems announced that it has been awarded a contract for up to $2.4 million from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to develop an MR compatible injection catheter for MRI-guided procedures. This ten month contract which has a two-year option period will support the continued advancement of real-time MRI guided interventions for the treatment of cardiac arrhythmias.